STOCK TITAN

[SCHEDULE 13G/A] Tonix Pharmaceuticals Holding Corp. Amended Passive Investment Disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Tonix Pharmaceuticals Holding Corp. ownership update: Point72 group reports beneficial ownership of 1,100,964 shares of Common Stock, representing 6.9% of the class as of the close of business on May 14, 2026. The filing attributes shared voting and dispositive power across Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen.

A footnote states that as of March 31, 2026 the reporting persons may have been deemed to beneficially own 125,414 shares (representing 0.9% as of that date). The statement clarifies that the reporting persons directly own no shares and that Point72 Associates holds the referenced securities.

Positive

  • None.

Negative

  • None.

Insights

Point72 holds a notable 6.9% stake in Tonix as of May 14, 2026.

Public filings show 1,100,964 shares reported under shared voting and dispositive power by Point72 entities and Mr. Cohen. The filing lists the ownership percentage as 6.9% with an May 14, 2026 time anchor.

Cash‑flow treatment and holder intentions are not disclosed in the excerpt; subsequent trading or sale activity will depend on decisions by the fund and its affiliates.

Filing emphasizes shared control and adviser structure rather than direct personal holdings.

The statement explains Point72 Asset Management as investment manager to Point72 Associates and names Point72 Capital Advisors Inc. as general partner; Mr. Cohen is identified as controller. The cover page footnote provides a separate March 31, 2026 beneficial‑ownership figure of 125,414 shares (0.9%).

Readers should note the filing language limiting admission of beneficial ownership under Section 13; the excerpt does not state any planned transactions or voting intentions.

Reported shares 1,100,964 shares Beneficial ownership reported as of May 14, 2026
Percent of class 6.9% Percentage of Common Stock as of May 14, 2026
Footnote shares 125,414 shares May have been deemed beneficially owned as of March 31, 2026
Footnote percent 0.9% Percentage of Common Stock as of March 31, 2026
CUSIP 890260839 Identifier for Tonix Common Stock
Filing date 05/15/2026 Signature dates on the amendment
Shared Dispositive Power regulatory
"Shared Dispositive Power 1,100,964.00 appears on the cover page"
Beneficially own regulatory
"may have been deemed to beneficially own 125,414 shares of Common Stock"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Schedule 13G/A regulatory
"This statement is filed by: Point72 Asset Management... (Schedule 13G/A amendment)"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





890260839

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the close of business on May 14, 2026. As of March 31, 2026, the Reporting Person may have been deemed to beneficially own 125,414 shares of Common Stock (as defined in Item 2(a)), representing 0.9% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the close of business on May 14, 2026. As of March 31, 2026, the Reporting Person may have been deemed to beneficially own 125,414 shares of Common Stock, representing 0.9% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the close of business on May 14, 2026. As of March 31, 2026, the Reporting Person may have been deemed to beneficially own 125,414 shares of Common Stock, representing 0.9% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026